Single-window for new drug approval: PanelThe committee, set up by the cabinet secretary after Prime Minister Narendra Modi sought overhauling of the country’s drug regulatory system, has suggested restructuring the process of permission for new drugs.
https://ift.tt/30wIhp9
0 Comments